Atara Biotherapeutics, Inc. (AT20)
Market Closed
17 Jul, 20:00
XFRA 
€
7. 35
+0.05
+0.6849%
€
70.28M Market Cap
- P/E Ratio
- Div Yield
186 Volume
-2.6 Eps
€ 7.3
Previous Close Want to track AT20 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Atara Biotherapeutics, Inc. (AT20) Statistics
Valuation metrics
Market Cap 70.28M
Enterprise value 61.03M
Trailing P/E (ttm) 3.46
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 3.04
Price/Book (mrq) -2.94
Enterprise Value/Revenue 3.07
Enterprise Value/EBITDA 9.28
Overview
Shares outstanding 8.51M
Float 4.74M
Shares short -
% Held by insiders 0.17%
% Held by institutions 0.49%
Average volume (10 days) 78
Average volume (90 days) 62
Price summary
52-Week low 3.48
52-Week high 16.3
Beta -0.29
50-Day moving average 5.04
200-Day moving average 8.59
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:25
Last split Date 20 Jun 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.41%
Operating margin -6.53%
Operational effectiveness
Return on assets 0.11%
Return on equity -0.85%
Income Statement
Revenue (ttm) 19.89M
Revenue per share (ttm) 1.73
Quarterly revenue growth (yoy) -0.99%
Gross profit (ttm) -2.32M
EBITDA 38.63M
Net income to common (ttm) -8.14M
Diluted EPS (ttm) -1.05
Quarterly earnings growth (yoy) -0.99%
Balance Sheet
Total cash (mrq) 7.19M
Total cash per share (mrq) 0.93
Total debt (mrq) 7.8M
Total Debt/Equity (mrq) -0.21
Current ratio (mrq) 2.16%
Book value per share (mrq) -3.77
Cash Flow
Cash flow statement -22.24M
Levered free cash flow (LFCF) -5.49M
